Amphastar Pharmaceuticals
AMPH
28.25
+0.14
+0.50%
Amphastar Pharmaceuticals
US · AMPH
#3194 by market cap
28.25
+0.14
+0.50%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
- Founded
- 1996
- CEO
- Dr. Jack Yongfeng Zhang, PhD
- Employees
- 1,976
- Headquarters
- Rancho Cucamonga, California, United States of America
- Fiscal year end
- 12-31
- Website
- amphastar.com
Company profile
- Exchange
- US
- Symbol
- AMPH
- Market-cap rank
- #3194
- Market cap
- 1.20B
- Float cap
- 887.31M
- Shares out
- 42.65M
- Float shares
- 31.41M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Cannabis & Hemp
Global medical industry
Fractional Shares JP
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Amphastar Pharmaceuticals discussion 0 comments